DARLING, RYAN JAMES,DICKINSON, CRAIG DUANE,DRIVER, DAVID ALBERT,GONCIARZ, MALGORZATA DONATA
申请号：
PE0022362014
公开号：
PE02012015A1
申请日:
2013.06.05
申请国别(地区):
PE
年份:
2015
代理人:
摘要：
The present Invention relates to Proteins of Human Fibroblast Growth Factor 21 (FGF21) pharmacologically potent and stable Pharmaceutical compositions comprising FGF21 Proteins, and Methods for treating Type 2 diabetes, obesity, dyslipidemia, and \/ or metabolic syndrome Using such ProteinsLA PRESENTE INVENCION SE REFIERE A PROTEINAS DEL FACTOR 21 DE CRECIMIENTO DE FIBROBLASTO HUMANO (FGF21) FARMACOLOGICAMENTE POTENTES Y ESTABLES, COMPOSICIONES FARMACEUTICAS QUE COMPRENDEN LAS PROTEINAS DEL FGF21, Y METODOS PARA TRATAR DIABETES TIPO 2, OBESIDAD, DISLIPIDEMIA, Y/O SINDROME METABOLICO USANDO TALES PROTEINAS
